Status:
COMPLETED
Drug-Drug Interaction Study With Rifampin
Lead Sponsor:
Bristol-Myers Squibb
Collaborating Sponsors:
PRA Health Sciences
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to determine if the concomitant administration of rifampin with BMS-708163 will affect the Pharmacokinetics of BMS-708163 and to assess safety and tolerability of co-admini...
Eligibility Criteria
Inclusion
- Healthy male and postmenopausal female subjects, 18-55 yrs old inclusive
Exclusion
- Women of childbearing potential
- Tuberculosis
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01002079
Start Date
August 1 2010
End Date
October 1 2010
Last Update
January 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Bangalore, India, 560100